Cathy Gwin
Senior Director, Communications
News
Media Contact
NTI Endorses Biosecurity Modernization and Innovation Act of 2026
NTI endorses the bipartisan Biosecurity Modernization and Innovation Act of 2026, led by Senators Tom Cotton (R-AR) and Amy Klobuchar (D-MN). This bill creates an important opportunity to incentivize a safe and secure U.S. bioeconomy through strengthened biosecurity policy.
New NTI Framework Tackles Misuse Risks in AIxBio Tools
New NTI | bio paper calls on tool developers and other AIxBio stakeholders to implement a managed access approach—allowing only validated users to access those biological AI models that contribute to biosecurity risks—to help reduce the risk that such tools will be deliberately misused to cause harm.
Introducing the Winners of the 2025 Next Generation for Biosecurity Competition
Students and early-career professionals from 19 countries across five continents entered the 2025 competition. The challenge called for innovative papers on how to define “biological weapons” in today’s ever evolving biothreat landscape.
NTI Welcomes Christine E. Wormuth as President and CEO
A national security leader with more than 30 years of experience in defense policy, strategic planning, and international security, Secretary Wormuth brings an extensive record of leadership and service at the Department of Defense, the White House, and prominent think tanks.
NTI Supports Tech-Driven Solutions to Modernize BWC Compliance
At the UN General Assembly President Trump announced his administration’s intention to harness artificial intelligence to help uphold the international ban on biological weapons. Using advanced technology to strengthen the Biological Weapons Convention is a promising step and an approach NTI has long supported.
B-roll North Korean Nuclear Test
B-Roll IRAN Natanz Enrichment Complex
B-roll Rattehalli Materials Plant - India
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
